Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Fluorine-18 Products Market by Type (NaF, FDG, Others), By Application (Hospital, Diagnostic Center, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Fluorine-18 Products Market by Type (NaF, FDG, Others), By Application (Hospital, Diagnostic Center, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 345323 4200 Pharma & Healthcare 377 233 Pages 4.9 (31)
                                          

Market Overview:


The global fluorine-18 products market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for fluorine-18 products in the hospital and diagnostic center applications. North America is expected to dominate the global fluorine-18 products market during the forecast period, followed by Europe and Asia Pacific.


Global Fluorine-18 Products Industry Outlook


Product Definition:


Fluorine-18 is a radioactive isotope of fluorine which is used in positron emission tomography (PET) scans. Fluorine-18 emits positrons, which are then detected by a PET scanner. This allows doctors to see how the brain and other organs are functioning.


NaF:


N-Fluorocarboxylic acid, commonly known as NaF, is an inorganic compound and a salt. It is a highly fluorine-rich organic chemical.


The growth factor for the market was high demand from nuclear medicine due to its use in imaging purposes and growing applications across pharmaceutical industries.


FDG:


Fluorine-18 (FDG) is a radiotracer used in radiotherapy for cancer. FDG is an analog of fluorine with 18 carbon atoms and one fluorine atom. It has been reported that the body’s natural stores of fluoride are usually sufficient to meet needs for fluoride ion (fluoride), which is used as an ingredient in toothpaste, drinking water, and other products.


Application Insights:


The global market is segmented by application into a hospital, diagnostic center, and others. The hospital application segment dominated the overall industry in terms of revenue in 2017. This can be attributed to the high usage rate of fluorine-18 for radiographic imaging and its growing use as an additive for diagnostic imaging due to its superior properties including bone scan image quality enhancement and improved soft tissue detection.


The other applications include industrial & research laboratories, dental care facilities, pharmaceutical companies, water treatment plants & systems (fluoride removal), metal plating processes (fluorine-18 add/removal), oil well drilling muds (fluoride removal) among others. These applications are expected to witness significant growth over the forecast period owing to increasing demand from end-use industries such as metal finishing or oil exploration services which require high purity products with low levels of impurities for their operations at optimum efficiency levels.


Regional Analysis:


North America dominated the global market in 2017. The presence of major fluorine-18 production facilities coupled with high demand for diagnostic products is expected to drive the regional market over the forecast period. In addition, increasing investments in R&D by key players are anticipated to fuel product penetration in this region.


Asia Pacific is estimated to be one of the fastest growing regions owing to rising healthcare expenditure and improving economic conditions especially in India and China.


In addition, favorable government initiatives such as “Make in India” campaign undertaken by Indian government are expected favorably impact industry expansion due to easy availability of skilled labor at competitive costs along with low manufacturing cost compared to developed economies within North America.


Growth Factors:


  • Increasing demand for PET imaging in oncology and neurology
  • Rising prevalence of cancer and other chronic diseases
  • Growing number of PET imaging centers worldwide
  • Technological advancements in Fluorine-18 Products industry
  • Increasing awareness about the benefits of PET imaging

Scope Of The Report

Report Attributes

Report Details

Report Title

Fluorine-18 Products Market Research Report

By Type

NaF, FDG, Others

By Application

Hospital, Diagnostic Center, Others

By Companies

Siemens Healthineers, Advanced Accelerator Applications, GE Healthcare, Blue Earth Diagnostics, Jubilant Pharma Limited, China lsotope & Radiation Corporation, Eli Lilly and Company, Yantai Dongcheng Pharmaceutical Group Co., Ltd., BV Cyclotron VU

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Fluorine-18 Products Market Report Segments:

The global Fluorine-18 Products market is segmented on the basis of:

Types

NaF, FDG, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Diagnostic Center, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Siemens Healthineers
  2. Advanced Accelerator Applications
  3. GE Healthcare
  4. Blue Earth Diagnostics
  5. Jubilant Pharma Limited
  6. China lsotope & Radiation Corporation
  7. Eli Lilly and Company
  8. Yantai Dongcheng Pharmaceutical Group Co., Ltd.
  9. BV Cyclotron VU

Global Fluorine-18 Products Market Overview


Highlights of The Fluorine-18 Products Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. NaF
    2. FDG
    3. Others
  1. By Application:

    1. Hospital
    2. Diagnostic Center
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Fluorine-18 Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Fluorine-18 Products Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Fluorine-18 products are isotopes of fluorine that have 18 protons in their atomic nucleus. These isotopes are used in medical imaging and nuclear medicine because they emit positrons, which can be used to image the body or diagnose diseases.

Some of the major companies in the fluorine-18 products market are Siemens Healthineers, Advanced Accelerator Applications, GE Healthcare, Blue Earth Diagnostics, Jubilant Pharma Limited, China lsotope & Radiation Corporation, Eli Lilly and Company, Yantai Dongcheng Pharmaceutical Group Co., Ltd., BV Cyclotron VU.

The fluorine-18 products market is expected to register a CAGR of 6.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fluorine-18 Products Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Fluorine-18 Products Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Fluorine-18 Products Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Fluorine-18 Products Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Fluorine-18 Products Market Size & Forecast, 2020-2028       4.5.1 Fluorine-18 Products Market Size and Y-o-Y Growth       4.5.2 Fluorine-18 Products Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 NaF
      5.2.2 FDG
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Diagnostic Center
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Fluorine-18 Products Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Fluorine-18 Products Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 NaF
      9.6.2 FDG
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Diagnostic Center
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 NaF
      10.6.2 FDG
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Diagnostic Center
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 NaF
      11.6.2 FDG
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Diagnostic Center
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 NaF
      12.6.2 FDG
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Diagnostic Center
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 NaF
      13.6.2 FDG
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Diagnostic Center
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Fluorine-18 Products Market: Competitive Dashboard
   14.2 Global Fluorine-18 Products Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Siemens Healthineers
      14.3.2 Advanced Accelerator Applications
      14.3.3 GE Healthcare
      14.3.4 Blue Earth Diagnostics
      14.3.5 Jubilant Pharma Limited
      14.3.6 China lsotope & Radiation Corporation
      14.3.7 Eli Lilly and Company
      14.3.8 Yantai Dongcheng Pharmaceutical Group Co., Ltd.
      14.3.9 BV Cyclotron VU

Our Trusted Clients

Contact Us